The Moment Of Truth For Three Alzheimer’s Drugs Beckons: What To Expect

Eisai/Biogen And Roche Phase III Readouts Expected Soon

 
• By Andrew McConaghie
  
Alzheimer's jigsaw
After the Aduhelm controversy, there is hope these drugs could offer a true breakthrough for people with early stage Alzheimer's. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Neurological

More from Therapeutic Category